Risuntek Inc (002981.SZ): Controlling shareholder acting in concert plans to reduce their stake in the company by no more than 3%.
Chaoyang Technology (002981.SZ) announcement, the company's shareholder holding 4.85% of the shares and the controlling shareholder of the company are acting in concert...
Risuntek Inc (002981.SZ) announced that its shareholder and controlling shareholder Ningbo Pengchen Entrepreneurship Investment Partnership Enterprise (Limited Partnership) ("Ningbo Pengchen"), which owns 4.85% of the company's shares, plans to reduce its shareholding by no more than 4,057,600 shares, or 3% of the total share capital of the company, within three months after the disclosure of the announcement.
Related Articles
Jiangsu Hengrui Pharmaceuticals (600276.SH): some drugs have obtained approval letters for clinical trials of drugs.
CSPC Pharma (01093) cancelled 25.45 million repurchased shares on May 9th.
On May 9, the Minerva Group (00397) spent approximately HK$287,800 to repurchase 4.3 million shares.
Jiangsu Hengrui Pharmaceuticals (600276.SH): some drugs have obtained approval letters for clinical trials of drugs.
CSPC Pharma (01093) cancelled 25.45 million repurchased shares on May 9th.
On May 9, the Minerva Group (00397) spent approximately HK$287,800 to repurchase 4.3 million shares.
RECOMMEND
General Administration of Customs: China's goods trade imports and exports increased by 2.4% year-on-year in the first 4 months.
09/05/2025
Key details are yet to be finalized. The market's response to the US-UK trade agreement has been lukewarm.
09/05/2025
Risk assets rebounded to boost the market, Bitcoin surged back above $100,000.
09/05/2025
